New Intermountain Healthcare Study Finds COVID Treatment Highly Effective in Preventing Hospitalizations, Severe Illness, and Death
In a new study, researchers from Intermountain Healthcare have found that treating high-risk COVID-19 patients with a monoclonal antibody treatment reduced severe illness and hospitalizations by more than 50 percent and saved many patients from dying due to complications from the virus.
View full press release